Shukra Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 10-07-2024
- Paid Up Capital ₹ 10.95 Cr
as on 10-07-2024
- Company Age 31 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.25 Cr
as on 10-07-2024
- Satisfied Charges ₹ 15.92 Cr
as on 10-07-2024
- Revenue 42.16%
(FY 2022)
- Profit 299.01%
(FY 2022)
- Ebitda 99.86%
(FY 2022)
- Net Worth 4.81%
(FY 2022)
- Total Assets 1.01%
(FY 2022)
About Shukra Pharmaceuticals
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524632.
The Corporate was formerly known as Relish Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 10.95 Cr.
The company currently has active open charges totaling ₹2.25 Cr. The company has closed loans amounting to ₹15.92 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Shukra Pharmaceuticals Limited India are Arpita Kabra as COMPANY SECRETARY and Mehulkumar Patel as Cfo. Dakshesh Shah, Payal Mehta, Sanskruti Patel, and Five other members serve as directors at the Company.
- CIN/LLPIN
L24231GJ1993PLC019079
- Company No.
019079
- Stock Symbol
BSE : 524632
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
04 Mar 1993
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Shukra Pharmaceuticals Limited offer?
Shukra Pharmaceuticals Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Milk & Dairy Products, Milk Powder, Animal Medicines & Health Care, Veterinary Bolus, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Common Disease Medicines, Injectable Products.
Who are the key members and board of directors at Shukra Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dakshesh Shah  | Managing Director | 26-May-2012 | Current |
| Arpita Kabra | Company Secretary | 04-Jan-2021 | Current |
| Mehulkumar Patel | CFO | 11-May-2020 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Payal Mehta | Director | 23-May-2012 | Current |
| Sanskruti Patel | Whole-Time Director | 16-Aug-2023 | Current |
| Sonal Gandhi | Director | 12-Aug-2023 | Current |
| Pinki Sagar | Director | Current | |
| Bhoomiben Patel | Director | 16-Jan-2019 | Current |
| Dhruvin Shah | Whole-Time Director | 16-Aug-2023 | Current |
Financial Performance and Corporate Structure Insights of Shukra Pharmaceuticals.
Shukra Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.16% increase. The company also saw a substantial improvement in profitability, with a 299.01% increase in profit. The company's net worth moved up by a moderate rise of 4.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shukra Pharmaceuticals?
In 2023, Shukra Pharmaceuticals had a promoter holding of 50.90% and a public holding of 49.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Navkar Urbanstructure LimitedActive 32 years 6 monthsSonal Gandhi, Pinki Sagar and 2 more are mutual person
Saptak Chem And Business LimitedActive 44 years 9 monthsSonal Gandhi and Bhoomiben Patel are mutual person
- Seher Retail Private LimitedActive 14 years 8 months
Dakshesh Shah and Sarjeevan Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tata Capital Financial Services Limited Creation Date: 16 Dec 2022 | ₹7.50 M | Open |
Tata Capital Financial Services Limited Creation Date: 28 Dec 2020 | ₹1.50 Cr | Open |
Hdfc Bank Limited Creation Date: 31 Dec 2016 | ₹3.25 Cr | Satisfied |
How Many Employees Work at Shukra Pharmaceuticals?
Shukra Pharmaceuticals has a workforce of 102 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shukra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shukra Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
